|
Abstract:
The Mediterranean diet
is rich in vegetables, cereals, fruit, fish, milk, wine and olive
oil and has salutary biological functions. Epidemiological studies
have shown a lower incidence of atherosclerosis, cardiovascular
diseases and certain kinds of cancer in the Mediterranean area.
Olive oil is the main source of fat, and the Mediterranean diet's
healthy effects can in particular be attributed not only to the high
relationship between unsaturated and saturated fatty acids in olive
oil but also to the antioxidant property of its phenolic compounds.
The main phenolic compounds, hydroxytyrosol and oleuropein, which
give extra-virgin olive oil its bitter, pungent taste, have powerful
antioxidant activity both in vivo and in vitro. The present review
focuses on recent works analysing the relationship between the
structure of olive oil polyphenolic compounds and their antioxidant
activity. These compounds' possible beneficial effects are due to
their antioxidant activity, which is related to the development of
atherosclerosis and cancer, and to anti-inflammatory and
antimicrobial activity.
Leaves of the privet
tree, Ligustrum obtusifolium, contain a large amount of oleuropein,
a phenolic secoiridoid glycoside, which is stably kept in a
compartment separate from activating enzymes. When the leaf tissue
is destroyed by herbivores, enzymes localized in organelles start to
activate oleuropein into a very strong protein denaturant that has
protein-crosslinking and lysine-decreasing activities. These
activities are stronger than ever reported from plant systems and
have adverse effects against herbivores by decreasing the nutritive
value of dietary protein completely. We report here that strong
oleuropein-specific β-glucosidase in organelles activates oleuropein
by converting the secoiridoid glucoside moiety of oleuropein into a
glutaraldehyde-like structure, which is also an α,β-unsaturated
aldehyde. Oleuropein activated by β-glucosidase had very strong
protein-denaturing, protein-crosslinking, and lysine-alkylating
activities that are very similar to, but stronger than, those of
glutaraldehyde. Aucubin, another iridoid glycoside, had similar
activities after β-glucosidase treatment. We also detected
polyphenol oxidase activity in organelles that activate the
dihydroxyphenolic moiety to have protein-crosslinking activities.
These data suggest that the privet tree has developed an effective
defense mechanism with oleuropein, a unique multivalent alkylator
ideal as a protein-crosslinker. Our results that iridoid glycosides
are precursors of alkylators may elucidate the chemical bases that
underlie various bioactivities and ecological roles of iridoid
glycosides.
Recently, the
importance of alkylating agents in plant–herbivore interactions has
been recognized. Alkylating agents, which include quinones, epoxides,
aldehydes, sesquiterpene lactone, pyrrolizidine alkaloids, etc., are
diverse in their chemical structure, but they all have electrophilic
atoms. These structures readily bind to various biological
nucleophiles, including nucleophilic side chains of proteins (e.g.,
-NH2 of Lys and -SH of Cys), and therefore exert adverse effects on
herbivores (e.g., loss of nutritive value caused by loss of Lys and
inactivation of enzymes), providing plants a chemical defense
against herbivores.
The privet tree,
Ligustrum obtusifolium (Oleaceae), is a small tree or a shrub that
is widespread throughout East Asia and has been naturalized recently
in the northeastern parts of the United States. Previously, we
reported that the leaves of the privet tree have very strong
protein-denaturing, protein-crosslinking, and lysine-decreasing
activities that could be explained in terms of alkylating
activities. When protein is mixed with the leaf extract, protein
denatures and forms a high-molecular-mass complex. At the same time,
the lysine content of the protein decreases to one-third to
one-fifth of the original, although other amino acids were not
affected. As a result, the protein loses its nutritive value.
Interestingly, addition of free glycine can inhibit all these
activities, and privet-specialist herbivores secrete free glycine in
the digestive juice as an adaptation. Purification study established
that the compound responsible for the denaturing activity is
oleuropein (Fig. 1), a phenolic secoiridoid glycoside found in
several Oleaceae species such as the olive tree. Oleuropein makes up
3% of the wet weight of privet leaves. However, this compound itself
is stable, does not have any of the activities, and is kept in the
vacuoles or cytosol of the leaf cell. When the leaves are
mechanically damaged by herbivory and cell compartments are broken,
enzymatic activity localized in organelles separate from oleuropein
starts to activate oleuropein into a very strong protein denaturant.
Although the alkylating activities of privet leaves are stronger
than those of other plants, the chemical mechanism of activation was
not clear.
Iridoids (iridoid
glycosides) are a group of terpene-derived compounds that have a
common structure. At present, almost 600 iridoids have been
described from plants of 57 families and are divided into three
groups: (i) nonglycosidic iridoids, which have no sugar moiety, such
as genipin (Fig. 1); (ii) iridoid glycosides, which typically have a
single glucose molecule and a closed cyclopentane ring, such as
aucubin and geniposide (Fig. 1); and (iii) secoiridoid glycosides,
which also have a glucose molecule but no cyclopentane ring, such as
oleuropein. Iridoids are known to have a variety of biological
effects and have been implicated to play roles in plant–herbivore
and prey–predator interactions. As iridoids generally are toxic or
deterrent to generalist herbivores, generalists usually experience a
reduced growth rate or are deterred from feeding on iridoid-containing
plants. However, iridoids have no negative effects on the feeding
and growth of herbivores that specialize in feeding on iridoid-containing
plants. Some of these specialists sequester a large amount of
iridoid and have conspicuous warning coloration. These insects are
toxic and unpalatable to predators such as birds and ants. Iridoids
are also reported to have antimicrobial , antitumor , hepatotoxic ,
bitter , and emetic features . Nevertheless, the chemical bases that
lie under these interesting characteristics of iridoids have not yet
been well explained.
In this study, we show
that the activation of the secoiridoid glycoside moiety of
oleuropein by substrate-specific β-glucosidase in organelles is
crucial for oleuropein to exert the strong
protein-denaturing/protein-crosslinking/lysine-alkylating activities
in privet leaves. We also show that other iridoid glycosides could
be similarly activated into alkylating agents by β-glucosidase and
discuss the chemical bases for the biological activities of
iridoids.
MATERIALS AND METHODS:
Materials. Oleuropein
was purified from the leaves of the privet tree (Ligustrum
obtusifolium) as described . Aucubin was purchased from Nacalai
Tesque (Kyoto). Geniposide, genipin, tropolone (polyphenol oxidase
inhibitor), catechol, 20% (vol/vol) glutaraldehyde solution,
ovalbumin, and p-nitrophenol were from Wako Pure Chemical Industries
(Osaka). p-Nitrophenyl-β-glucopyranoside was from Senn Chemicals (Dielsdorf,
Switzerland). β-Glucosidase (sweet almond) was purchased from
Oriental Yeast (Osaka).
Preparation of Crude
Enzyme Fraction (Organelle Fraction) from Privet Leaves. The enzyme
fraction of the privet tree, which contains oleuropein-activating
enzymes but not oleuropein, was prepared as described . In short, 16
g of fresh privet leaves were homogenized in 100 ml of
high-osmotic-pressure sucrose solution (0.4 M sucrose/0.1 M sodium
phosphate, pH 7) to collect intact organelles. After differential
centrifugation and subsequent washing in the same buffer, collected
organelles were resuspended in 20 ml of the same buffer. This
suspension of intact organelles, where oleuropein-activating enzymes
are localized, was used as the enzyme fraction. Breaking the
organelles, a necessary step in assaying the enzyme activities
inside them, was accomplished automatically when the organelles were
burst in reaction solutions with low osmotic pressure.
Assays of
Protein-Denaturing/Protein-Crosslinking/Lysine-Decreasing Activity.
The activities were examined by testing whether ovalbumin would be
denatured. All the assays were performed in 375 μl of 0.1 M sodium
phosphate buffer (pH 7.0), containing 1% ovalbumin and 250 μl of 0
or 11 mM solutions of chemicals whose activities were to be measured
(i.e., oleuropein, catechol, glutaraldehyde, geniposide, genipin,
and aucubin). In trials designed to examine the effects of enzymes,
375-μl volumes of the reaction solutions also included 50 μl of the
enzyme fraction of privet leaves or 50 μl of β-glucosidase solution,
which contained 5 units of β-glucosidase (from sweet almond). Assays
were performed in triplicate at 25°C for 2 h in 1.5-ml microfuge
tubes with vigorous shaking. The effect of tropolone (polyphenol
oxidase inhibitor; chelator of copper ion; refs. 21 and 22) on the
denaturing activity was assayed by preincubating the 50-μl volumes
of enzyme solutions with 90 μg of tropolone for 10 min before the
initiation of the reaction; 5 μl of the reaction solution was
applied to SDS/PAGE to determine the protein-denaturing/protein-crosslinking
activities. The degree of denaturation and crosslinking was
determined by the band pattern. For amino acid analysis, 1 ml of 6 M
HCl and 700 μl of water were added to 300 μl of the reaction
solution and hydrolyzed for 22 h at 110°C. After removal of HCl,
lysine contents were analyzed with an auto amino acid analyzer
(model L5000, Hitachi, Tokyo).
Assay of β-Glucosidase
Activity and Assessment of the Degree of Deglucosidation. β-Glucosidase
activity of the enzyme fraction (organelle fraction) on oleuropein,
aucubin, and geniposide was assayed by measuring the amounts of
glucose produced in the reaction solutions. To assay β-glucosidase
activity of the enzyme fraction on oleuropein, an enzyme reaction
was performed in triplicate in 375 μl of 0.1 M sodium phosphate
buffer (pH 7.0) containing 250 ml of 11 mM solution of oleuropein,
10 μl of the enzyme fraction, and 90 μg of tropolone for 15 min at
25°C. Tropolone was preincubated with the enzyme fraction to inhibit
the interference of polyphenol oxidase activity as described above.
To assay β-glucosidase activity of the enzyme fraction on aucubin
and geniposide, enzyme reactions were performed in 375 μl of 0.1 M
sodium phosphate buffer (pH 7.0) containing 50 μl of the enzyme
fraction and 250 ml of either 11 mM aucubin or geniposide at 25°C
for 2 h. These conditions were within the linear range. Reactions
were stopped by heat inactivation (96°C for 5 min). After
centrifugation and filtration, 100-μl volumes of the supernatants
from the reaction solutions were injected into an STR-ODS-H column
(150 × 4.6-mm i.d., 5 μm; Shimadzu) to separate the produced glucose
from chemicals that interfere with the detection of glucose. The
column temperature was 40°C, and the flow rate was 1.0 ml/min. The
gradient was as follows: 0–10 min, 0–70% (vol/vol) ethanol in water
(linear gradient) and then 10–15 min, 70% ethanol (isocratic). A
1-ml volume of glucose-containing fraction of each sample was
collected between 1.0 and 2.0 min, and the glucose concentration was
analyzed by using GOD-PODLK (Nagase Biochemical, Kyoto), a glucose
assaying kit based on a glucose oxidase-peroxidase-chromogen system,
which uses phenol as a substrate of peroxidase and 4-aminoantipyrine
as a chromogen. Absorbance at 505 nm was measured. Glucose solutions
of known concentrations in 0.1 M sodium phosphate buffer (pH 7.0)
were also analyzed as standards by using HPLC and GOD-PODLK.
To assess the degree of
deglucosidation of oleuropein and other iridoid glycosides by the
enzyme fraction (organelles) or β-glucosidase, assays were performed
in 375 μl of 0.1 M sodium phosphate buffer (pH 7.0) containing 11 mM
solutions of an iridoid glycoside (oleuropein, geniposide, or
aucubin) and 50 μl of the enzyme fraction of privet leaves or 50 μl
of β-glucosidase solution, which contained 5 units of β-glucosidase
(from sweet almond). In the reaction of oleuropein and the enzyme
fraction of the leaves, the enzyme fraction was preincubated with
tropolone as described above. Assays were performed in triplicate at
25°C for 2 h in 1.5-ml microfuge tubes with vigorous shaking. The
glucose produced was analyzed as described above.
To assay the β-glucosidase
activity of the enzyme fraction on p-nitrophenyl-β-glucopyranoside,
a reaction was performed in 375 μl of 0.1 M sodium phosphate buffer
(pH 7.0) containing 250 μl of 11 mM p-nitrophenyl-β-glucopyranoside,
90 μg of tropolone, and 50 μl of the enzyme fraction at 25°C for 2
h. After the reaction, 100 μl of the reaction solution was mixed
with 2 ml of 1 M Na2CO3, and then absorbance at 450 nm was measured.
The degree of deglucosidation was determined by comparing this
absorbance with that of p-nitrophenol at 450 nm .
RESULTS:
Protein-Denaturing/Protein-Crosslinking/Lysine-Decreasing Activities
of Oleuropein: Activation of Phenolic Moiety by Polyphenol Oxidase.
Oleuropein itself did not have any protein-denaturing and
lysine-decreasing activities. There was no difference in SDS/PAGE
pattern and lysine content between untreated ovalbumin and ovalbumin
treated only with 11 mM oleuropein (Fig. 2 A and B, lanes 1 and 2).
When organelles (the enzyme fraction), which have no
protein-denaturing and lysine-decreasing activities (7), were added
together in the mixture of ovalbumin and oleuropein, ovalbumin was
denatured and high-molecular-mass crosslink products were formed,
which are visible in the disappearance of the main band and in the
appearance of fuzzy bands in the upper part of the stacking and
separation gels (Fig. 2A, lane 3). At the same time, the lysine
content of the treated protein decreased to approximately one-third
of the original content (Fig. 2B, lane 3), but other amino acids
were not affected (data not shown, but see refs. 6 and 7). These
results suggest that activation by enzymes retained in organelles is
necessary for oleuropein to exert its protein-denaturing/protein-crosslinking/lysine-decreasing
activities.
To elucidate the
chemical process of enzymatic activation of oleuropein, we first
examined whether activation of the phenolic moiety is involved. The
rapid browning that we observed when we mixed oleuropein and the
enzyme fraction together, a hallmark of polyphenol oxidation and
polymerization, supported the idea that the phenolic moiety is
involved. Catechol (11 mM), a dehydroxyphenolic moiety of oleuropein
itself, did not have any of the activities on ovalbumin without
enzymatic activation (Fig. 2 A and B, lane 4). When mixed with the
enzyme fraction (organelles) of privet leaves, 11 mM catechol had
certain protein-denaturing/protein-crosslinking/lysine-decreasing
activities (Fig. 2 A and B, lane 5) that were weaker than those
observed when 11 mM of oleuropein was mixed with the enzyme fraction
(Fig. 2, lane 3). The color of the reaction solution changed to dark
brown. However, when we added 90 μg of tropolone (final
concentration of 2 mM), a polyphenol oxidase inhibitor (21, 22), to
the reaction between catechol and the enzyme fraction, all the
activities and the browning of the reaction solution were inhibited
completely (Fig. 2, lane 6). These data suggest that the enzyme
fraction of privet leaves has a certain polyphenol oxidase activity
that activates the phenolic moiety of oleuropein to some extent.
However, contrary to our expectations, tropolone did not inhibit the
protein-denaturing/protein-alkylating/lysine-decreasing activities
of oleuropein activated by the enzyme fraction of privet leaves
(Fig. 2, lane 7), although browning was inhibited completely. This
result strongly suggested that some activation mechanism other than
oxidation of the phenolic moiety exists and plays a greater role.
Protein-Denaturing/Protein-Crosslinking/Lysine-Decreasing Activities
of Oleuropein: Activation of Iridoid Glycoside Moiety by β-Glucosidase.
Next, we investigated the iridoid glycoside moiety and hypothesized
that, if glucose is removed, after the ring-opening reaction in the
hemiacetal-like structure and subsequent keto-enol conversion, the
iridoid glycoside moiety may form a glutaraldehyde-like structure
(Fig. 1). This conversion had been suggested to occur by several
researchers (18, 20, 26), but its chemical, physiological and
ecological consequences had not been studied in detail. As
glutaraldehyde is well known as an potent alkylator, crosslinker,
and denaturant of protein and is used to fix protein in
histochemical studies (27–31), we hypothesized that the same
reaction might occur in our system. To examine this possibility, we
mixed 11 mM oleuropein with 5 units of β-glucosidase from sweet
almond. Oleuropein incubated with β-glucosidase had
protein-denaturing/protein-crosslinking/lysine-decreasing activities
(Fig. 2 A and B, lane 8) just as strong as those observed when
oleuropein was activated by the enzyme fraction of privet leaves in
the presence of tropolone (Fig. 2, lane 7). Browning of the reaction
solution did not occur at all. We next examined whether
glutaraldehyde has similar activities. Glutaraldehyde had activities
(Fig. 2, lane 9) that are stronger than those observed in catechol
activated by the enzyme fraction of privet leaves (Fig. 2, lane 5)
but weaker than those observed in oleuropein activated by β-glucosidase
(Fig. 2, lane 7). We further examined whether other iridoid
glycosides are activated by β-glucosidase and by the enzyme fraction
of privet leaves as well. Aucubin, which does not have any of the
activities itself (Fig. 2 A and B, lane 14), had considerably strong
activities when activated by β-glucosidase from sweet almond (Fig.
2, lane 15). The lysine-decreasing activity was as strong as that of
glutaraldehyde (Fig. 2B, lanes 9 and 15), and the
protein-denaturing/protein-crosslinking activities were stronger
than those of glutaraldehyde and equaled those of oleuropein, as
determined by the SDS/PAGE pattern (Fig. 2A, lanes 7–9 and 15).
However, aucubin was not activated by the enzyme fraction of privet
leaves (Fig. 2, lane 16). Geniposide, another iridoid glycoside that
also has no activities itself, had weak activities after activation
by β-glucosidase or by the enzyme fraction (Fig. 2 A and B, lanes
10–12). Geniposide is different from other iridoid glycosides in
that its aglycone is relatively stable and is available as genipin.
In agreement with this result, genipin had weak activities (Fig. 2,
lane 13). All of these data indicate that oleuropein and other
iridoid glycosides could be activated by β-glucosidase to exert
activities very similar to those of privet leaves and
glutaraldehyde.
β-Glucosidase
Activity in the Enzyme Fraction Is Highly Specific to Oleuropein. To
examine whether β-glucosidase really exists and plays a crucial role
in privet leaves, we assayed β-glucosidase activity in the enzyme
fraction (organelles) of privet leaves on oleuropein and other
related β-glucosides (Table 1). The enzyme fraction (organelles)
derived from 1 g of fresh privet leaves had 5.22 ± 1.01 μmol/min β-glucosidase
activity on oleuropein. As 1 g of fresh leaves contains 55.5 μmol of
oleuropein, the data show, theoretically, that the β-glucosidase
activity is strong enough to deglucosidate and activate all the
oleuropein in privet leaves in about 10 min. With geniposide as a
substrate, the enzyme fraction from 1 g of fresh leaves had 0.142 ±
0.004 μmol/min β-glucosidase activity. With aucubin as a substrate,
the same enzyme fraction had practically no activity (0.000 ± 0.000
μmol/min). With p-nitrophenyl-β-glucopyranoside, an artificial
substrate often used in assaying β-glucosidase activity, as a
substrate, this enzyme fraction had 0.029 ± 0.002 μmol/min activity.
These data indicate that the enzyme fraction (organelles) of privet
leaves has a strong and substrate-specific β-glucosidase activity on
oleuropein and suggest that this β-glucosidase activity is the major
factor that activates oleuropein in privet leaves.
Degree of
Deglucosidation in Assaying Conditions. To interpret the results
shown in Fig. 2 in greater detail, we examined the degree of
deglucosidation in the assaying conditions by measuring the amounts
of glucose produced after the reactions (Table 2). The enzyme
fraction of privet leaves deglucosidated 92.2 ± 2.9% of oleuropein
in the presence of tropolone (corresponding to lane 7 of Fig. 2). β-Glucosidase
from bitter almond deglucosidated 40.9 ± 3.6% of oleuropein (Fig. 2,
lane 8). The enzyme fraction of privet leaves deglucosidated 24.8 ±
0.7% of geniposide (Fig. 2, lane 11), and β-glucosidase
deglucosidated 100.3 ± 12.9% of geniposide (Fig. 2, lane 12).
Although β-glucosidase deglucosidated 34.4 ± 5.0% of aucubin (Fig.
2, lane 15), the enzyme fraction did not deglucosidate aucubin in
assaying conditions (0.0 ± 0.0%; Fig. 2, lane 16). These enzyme
assays based on the appearance of glucose showed good agreement with
those based on the decrease of iridoid glycosides in the reaction
solutions (as estimated by peak areas in HPLC) and also were in good
agreement with those based on the appearance of genipin when
geniposide was used (data not shown). In the case of oleuropein and
aucubin, however, the corresponding aglycones were not observed in
the reaction solutions as HPLC peaks, probably because of the
instability of these aglycones. These data suggest that the
inability of the enzyme fraction of privet leaves to activate
aucubin is caused by its inability to deglucosidate aucubin and that
the inability of the enzyme fraction to activate geniposide is
caused by the inactivity of the corresponding aglycone. For an
iridoid glycoside to exert strong activities, both the activeness of
aglycone and the existence of efficient β-glucosidase are necessary.
The oleuropein system of the privet tree seems to fulfill both
criteria.

Figure 1
Structures of oleuropein and its related compounds.

Figure 2.Protein-denaturing/protein-crosslinking/lysine-decreasing
activities of oleuropein, catechol, glutaraldehyde, and iridoid
glycosides in the presence of the enzyme fraction of privet leaves
(organelles), β-glucosidase, or tropolone (polyphenol oxidase
inhibitor). (A) Protein-denaturing/protein-crosslinking activities
on ovalbumin as assayed by SDS/PAGE. The degree of denaturation and
crosslinking is indicated by the disappearance of the main band of
ovalbumin and the appearance of fuzzy bands in the upper parts of
stacking and separation gel. (B) Lysine-decreasing activity. After
hydrolysis, the lysine content of ovalbumin in reaction solution was
analyzed with an auto amino acid analyzer (Hitachi). Error bars
represents SD (n = 3).

Figure 3.Proposed
chemical model of oleuropein activation in the privet tree,
Ligustrum obtusifolium.
表1
|
Oleuropein |
5.22 ± 1.01
|
|
Geniposide |
0.142 ± 0.004
|
|
Aucubin |
0.000 ± 0.000
|
|
p-
Nitrophenyl? glucoside |
0.029 ± 0.002 |
‑
SD (n
= 3) 。
Table 2.Percentage
of deglucosidation of iridoid glycosides in conditions corresponding
to those indicated in Fig.
|
Reaction |
Deglucosidation* |
|
Oleuropein + enzyme fraction
+ tropolone |
92.2 ± 2.9(7)
|
|
Oleuropein + β-glucosidase |
40.9 ± 3.6(8)
|
|
Geniposide + enzyme fraction |
24.8 ± 0.7(11)
|
|
Geniposide + β-glucosidase |
100.3 ± 12.9(12)
|
|
Aucubin + β-glucosidase |
34.4 ± 5.0(15)
|
|
Aucubin + enzyme fraction |
0.0 ± 0.0(16) |
*Mean
± SD (n = 3); The numbers in parentheses correspond to the
lane numbers in Fig.
†The
enzyme fraction (organelle) of privet leaves.
‡β-Glucosidase
from sweet almond.
Antimicrobial properties – manufacturing problems:
The second
historical source indicating that components of the olive tree had
biologically important properties came from the European olive
fermentation industry. Up until the 1970s, the industry had suffered
problems in the fermentation of olives, a process involving lactic
acid pickling, because of strong resistance of the fresh fruits to
the action of lactic acid bacteria.5,6,7,8
In 1960,
Panizzi et al9 had isolated a bitter glucoside, oleuropein, from
olive leaves, with the empirical formula C25H32O13. The substance,
later determined to be a phenolic compound belonging to the iridoid
group,10 was also present in the olive itself. Oleuropein, as with
Pallas’ “Vauqueline”, was considered to be the source of the olive
tree’s powerful disease-resistant properties. It was subsequently
found that removal of oleuropein from olives enabled fermentation to
take place successfully.
The olive
oil manufacturing industry had also long been well aware of the rich
antibacterial properties of the olive tree. The manufacturing
process involves milling of olive paste and continuous washing with
water, known as malaxation. The waste waters from this process were
generally discarded; however, it was found that if the waters found
their way into the soil, they displaced beneficial bacterial flora
and adversely affected the natural biodegradation process.
The active
ingredient in olive leaf extract is called oleuropein. Oleuropein is
a polyphenolic fraction derived from the fruit, leaves, bark and
roots of the olive tree, which help make it strongly resistant to
damage from insects and other factors. Oleuropein is known as an
iridoid, a type of plant chemical found throughout the olive tree
and in olive oil.
Within
Oleuropein is a chemical agent called elenolic acid, which has been
shown to assist the body's immune defense. Research studies have
found that elenolic acid helps the body to balance levels of
friendly bacteria and support the immune system.
The
energy-boosting benefits of olive leaf extract are believed to be
the result of its ability to help fend off fungi, which overtax the
immune system, and yeast overgrowth (such as Candida albicans),
which cause fatigue.
Olive leaf
extract provides nutritional support for detoxification at the
cellular level, when the body is under stress. It has been shown to
protect RNA structure.
The chemical components:
Over a
period of more than 30 years since Panizzi et al’s9 isolation of
oleuropein, extracts from various parts of the olive tree have been
extensively investigated. Oleuropein appears to be present
throughout the olive tree, including leaves, buds, fruit, wood, bark
and roots.16,3,17,18 Olive leaves contain around 60—90 mg per gram
(dry weight) oleuropein,19 plus
significant
levels of a glucosidic ester of elenolic acid and hydroxytyrosol
(3,4-dihydrophenylethanol). However, it turns out that oleuropein
and the products of its hydrolysis, oleuropein aglycone, elenolic
acid, beta-3,4-dihydroxyphenyethyl alcohol and methyl-o-methyl
elenolate,20 are the major molecules of interest biologically.
Nature's Antimicrobial Agent:
Oleuropein,
the bitter glucoside lodged in leaves of the green olive tree (Olea
europaea), and products of its hydrolysis, contain components
valuable for treating both infectious and degenerative diseases. The
empirical formula of oleuropein (C25H32O13) makes it a member of the
iridoid group, a uniquely structured chemical class that contains a
carbohydrate component appearing as D-glucose.
The first
iridoid found in nature, verbenalin, was isolated circa 1835. No
investigation into the group's structure began until 1963 because
iridoids are extremely unstable--one member of the iridoid group has
the capability to transfer into another group. This biogenetic
characteristic gives the iridoid oleuropein its therapeutic
antimicrobial power.11
In a
document describing how oleuropein works, James R. Privitera, M.D.,
of Covina, Calif., says olive leaf extract brings about:
* A
critical interference with certain amino acid production processes
necessary for the vitality of a specific virus, bacterium or
microbe;
*
Interference with viral infection and/or spread by inactivating
viruses or by preventing virus shedding, budding or assembly at the
cell membrane;
* Direct
penetration into infected host cells and irreversible inhibition of
microbial replication;
*
Neutralization of the retrovirus' production of reverse
transcriptase and protease. These enzymes are essential for a
retrovirus such as human immunodeficiency virus (HIV) to alter the
ribonucleic acid (RNA) of a healthy cell;
* Direct
stimulation of phagocytosis as an immune system response to germs of
all types.
Oleuropein
is a stable chemical except in nature, where certain environmental
alterations cause molecular properties to change. For example,
during the several thousand years olive leaves have been
antimicrobial, pathogenic microorganisms have continued to be
adversely affected by the olive leaves' oleuropein. This may
indicate that the chemical structure of oleuropein tends to alter
with the microbes' mutations, allowing it to continue inhibiting
their growth, spread or survival. In contrast, synthetic antibiotics
do not change to maintain resistance to bacteria.
The Post Antibiotic
Era:
According
to well-documented scientific evidence, the myriad of pharmaceutical
antibiotics developed over the past fifty years are no longer as
effective against bacterial infections as they once were. Bacteria
have developed antibiotic resistant mechanisms, which negate the
protective effect of many antibiotics commonly used today. Proof of
this is that over 2 million people are infected in hospitals every
year even when given antibiotics to prevent infection.
Bacteria
replicate at very accelerated rates inside an infected animal and if
the bacterial numbers exceed the capabilities of the immune defense,
dire consequences follow. Bacteria bring about illness by churning
out micro-toxins or by digesting and breaking down tissues.
Antibiotics
work by killing the growing bacterial colony in one of three
methods:
l
By interfering with the microbe ability to build its cell wall
(penicillin works this way).
l
By interfering with the mechanism used by bacteria to assemble
vital proteins (as shown by erythromycin and tetracycline).
l
By binding to the bacterial chromosomes and shutting down
reproduction. Pain Reduction
In order to
work, antibiotics must penetrate the bacterium or bind to the outer
membrane of the cell wall. With the excessive use of antibiotics
over the past 20 years, bacteria have been able to develop mutation
strategies, which no longer allow the antibiotic to penetrate the
bacteria or bind to the cell. Microbes also have been able to
neutralize the antibiotics by using immunological genes called
plasmids (small circular strands of DNA). These plasmids help the
bacteria to generate enzymes, which can actually destroy the
antibiotic and render it harmless. When "Super bugs" come on the
scene, it requires a whole new class of more sophisticated
antibiotics to overcome them. The problem is that the pharmaceutical
industry is not keeping up.
For
instance, the super new strain of staphylococcus, although once
killed by Penicillin, now has adapted to inactivate every antibiotic
used against it except Vancomycin, a potent antibiotic that
unfortunately also has major adverse side effects.
Antibiotic resistant bacteria have led to a big increase in ear,
lung and sinus infections in children and adults. Drug resistant
food-born salmonella cases have drastically increased since 1979.
Pharmaceutical companies are having difficulty in developing new
super antibiotics to treat these drug-resistant bacteria. They have
failed in many cases to produce anti-viral medicines that are
effective against many of the super bugs now evolving.
Olive Leaf
Extract has now shown itself to be an answer and possible approach
to overcome and destroy these super antibiotic resistant
microorganisms. Clinical and laboratory studies have clearly shown
that the active ingredient in Olive Leaf Extract will kill most
viruses, all types of resistant bacteria, Anthrax, yeast, parasites
as well as influenza virus, Ebola, HIV and other emerging viruses.
This discovery may well provide the safety, protection and healing
power in those cases where medical science and drug research have
not provided an answer.
Table : Results
from the Use of Olive Leaf Extract Against Pathological Organisms -
Viruses, Bacteria, and Fungi
|
Disease
Entities |
No of Patients |
Fully
Recovered |
Improved |
Unchanged |
Deteriorated |
|
Respiratory
diseases (tonsillitis, pharyngitis, tracheitis, etc.) |
119 |
115 |
4 |
none |
none |
|
Lung
conditions (pneumonia, bronchitis, etc.) |
45 |
42 |
3 |
none |
none |
|
Dental
problems (pulpitis, leukoplakia, stomatitis) |
67 |
60 |
5 |
2 |
none |
|
Skin
conditions (herpes and other viral skin problems) |
172 |
120 |
52 |
none |
none |
|
Bacterial skin
infections (pyoderma, injuries) |
37 |
30 |
7 |
none |
none |
|
Ulcer disease
(while experiencing Helicobacter pylori infection) |
17 |
none |
17 |
none |
none |
|
Strengthened
immunity |
43 |
n/a |
40 |
3 |
none |
Antibacterial actions – in vitro studies:
A variety
of antibacterial actions of oleuropein and its associated compounds
have been demonstrated in vitro. Fleming et al8 isolated six major
phenolic compounds from green olives; one particular compound,
possibly a hydrolysis product of oleuropein, was much more
inhibitory than oleuropein itself to the lactic acid bacterium
Leuconostoc mesenteroides FBB 42. Later on, the oleuropein aglycone
and elenolic acid were found to strongly inhibit the growth of three
further species of lactic acid bacteria
– Lactobacillus plantarum, Pediococcus cerevisiae, and Lactobacillus
brevis.20 Since the aglycone is composed of elenolic acid bound to
b-3,4-dihydroxyphenylethyl alcohol, and the latter compound was not
inhibitory, the investigators concluded that elenolic acid was the
inhibitory part of the aglycone molecule. Oleuropein itself was not
inhibitory to these bacteria, but did inhibit three species of
non-lactic acid bacteria – Staphylococcus aureus, Bacillis subtilis
and Pseudomonas solanecearum. In addition, an acid hydrolysate of an
extract of oleuropein (containing hydrolysis products of oleuropein
not specifically identified) inhibited the growth of a further eight
species of bacteria.
Some more
recent in vitro studies have shown that oleuropein and/or its
hydrolysis products also inhibit the germination and sporulation of
Bacillus megaterium15 and inhibit outgrowth of germinating spores
of Bacillus cereus T.
Oleuropein: A Potent Antioxidant\

Oleuropein, an active constituent of olive oil and olive leaf, was
investigated by Coni and coworkers1. The researchers conducted an in
vivo study that evaluated oleuropein’s effects on the serum low
density lipoprotein (LDL) levels in rabbits. The study was carried
out on the basis of the positive results obtained with in vitro,
pilot studies on human LDL. The results of these pilot studies
indicated that certain constituents in olive oil inhibited
prooxidative processes in human LDL.
The
rabbits were fed special diets. Diet A consisted of a standard diet
for rabbits. Diet B consisted of the standard diet plus 10% (w/w)
extra virgin olive oil, and Diet C consisted of the standard diet
plus 10% (w/w) extra virgin olive oil and 7 mg/kg oleuropein. In
order to evaluate oleuropein’s effect, biochemical parameters
identified in the rabbits’ blood plasma and LDL were measured before
and after copper-induced oxidation.
The
results verified the antioxidant efficacy of extra virgin olive
oil’s biophenols, particularly oleuropein. In measuring the presence
of conjugated dienes in the rabbits’ LDL, it was determined that
rabbits fed Diet C had a lesser amount of conjugated dienes and
therefore of lipid radicals than either rabbits fed Diets A or B.
The amounts of conjugated dienes present in the LDL were 51.0 ± 9.3
µM, 25.8 ± 4.1 µM, and 19.8 ± 3.9 µM for rabbits fed Diet A, Diet B,
and Diet C, respectively. Similarly, evaluation of other ox-LDL
(oxidized LDL) parameters followed the same trend. These results
indicate that oleuropein increased the ability of LDL to resist
oxidation.
In
addition to oleuropein’s antioxidant properties, it was determined
that Diet C reduced the rabbits’ plasma levels of total, free, and
ester cholesterol by 15%, 12%, and 17%, respectively, compared to
rabbits fed Diet B. This reduction caused a redistribution of the
lipid components of LDL with an indirect effect on the dimensions.
|